iRadimed
IRMD
$44.70
Share price
1.94%
Change (1 day)
3.59%
Change (1 year)
Categories
iRadimed (IRMD) - Cash on Hand
Cash on Hand as of December 2023 : $49.76 M
According to iRadimed's latest financial reports the company has $49.76 M in cash and cash equivalents.
A company’s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.
iRadimed - Cash on Hand chart (from 2013 to 2023)
Cash on Hand by year
| Year | Cash on Hand | Change |
|---|---|---|
| 2023-12-31 | $49.76 M | -14.15% |
| 2022-12-31 | $57.96 M | -7.26% |
| 2021-12-31 | $62.5 M | 20.25% |
| 2020-12-31 | $51.97 M | 12.38% |
| 2019-12-31 | $46.25 M | 34.54% |
| 2018-12-31 | $34.37 M | 30.51% |
| 2017-12-31 | $26.34 M | 2.58% |
| 2016-12-31 | $25.67 M | -4.79% |
| 2015-12-31 | $26.97 M | 55.29% |
| 2014-12-31 | $17.36 M | 541.41% |
| 2013-12-31 | $2.7 M | 39% |
| 2012-12-31 | $1.94 M |
Cash on Hand for similar companies or competitors
| Company | Cash on Hand | differencediff. | Country |
|---|---|---|---|
 Edwards Lifesciences EW | $1.64 B | 3,204.72% | 🇺🇸 USA |
 NuVasive NUVA | $80.71 M | 62.21% | 🇺🇸 USA |
 DexCom DXCM | $2.89 B | 5,721.69% | 🇺🇸 USA |
 AtriCure ATRC | $0.13 B | 175.88% | 🇺🇸 USA |